In contrast, the majority of non-Mexican Hispanics were observed to have hyperlipidemia (50.9% vs. 24.9%) and the HR+ (especially ER+) tumor subtype (76.3% vs. 67.9%, p = 0.03). This evidence concerns the gene ESR1 and hyperlipidemia.